Washington hospital covid-19 patient Washington

Convalescent plasma for COVID-19: Study says treatment of no benefit to most

Reading now: 866
www.fox29.com

WASHINGTON - The final results of a clinical trial show convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, the National Institutes of Health announced Wednesday.Last year, the U.S.

Food and Drug Administration issued an Emergency Use Authorization for convalescent plasma in hospitalized patients with COVID-19.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA